President Trump speaks during a press briefing with FDA commissioner Stephen Hahn (left) and White House coronavirus response coordinator Deborah Birx (right) of the coronavirus task force, at the White House, Thursday, March 19, 2020, in Washington. (AP Photo/Evan Vucci)
March 20, 2020 07:31 AM EDTUpdated 08:30 AM
Bioregnum
Coronavirus
Opinion

No, Mr. Pres­i­dent, you can’t just or­der up out­break meds with the snap of your fin­gers

Don­ald Trump was in clas­sic freestyle speak­ing mode on Thurs­day as he talked up the im­me­di­ate pro­duc­tion of drugs that can fight the new coro­n­avirus …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

TRENDING NOW

Rev­o­lu­tion’s KRAS drugs ap­pear com­pet­i­tive in sev­er­al lung can­cer set­tings

Lil­ly shuf­fles key ex­ec­u­tive po­si­tions; Mikael Dol­sten takes an­oth­er post-Pfiz­er as­sign­ment

As­traZeneca re­ports Phase 3 win for Imfinzi; Roche to build new man­u­fac­tur­ing site in Chi­na

Io­vance stock plum­mets af­ter low­ered full-year guid­ance, missed an­a­lyst ex­pec­ta­tions for Am­tagvi

Corvus' ear­ly-phase atopic der­mati­tis da­ta prompt stock ral­ly

sponsored

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

A service from the Financial Times